Alliance Pharma plc (LON:APH – Get Rating)’s stock price passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 73.19 ($0.89) and traded as low as GBX 58.97 ($0.72). Alliance Pharma shares last traded at GBX 61.20 ($0.75), with a volume of 1,505,353 shares changing hands.
Wall Street Analyst Weigh In
Separately, Berenberg Bank reiterated a “buy” rating and issued a GBX 145 ($1.77) price objective on shares of Alliance Pharma in a research report on Tuesday, September 20th.
Alliance Pharma Stock Performance
The stock has a market capitalization of £330.48 million and a P/E ratio of 3,060.00. The company’s 50-day moving average is GBX 52.57 and its two-hundred day moving average is GBX 73.19. The company has a current ratio of 1.93, a quick ratio of 1.42 and a debt-to-equity ratio of 45.88.
Alliance Pharma Company Profile
Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. It holds the marketing rights of approximately 80 consumer healthcare and prescription medicine products.
- 3 Small-Cap Biopharma Stocks that Could See Big Growth in 2023
- Optimism About Global Demand For Metals Boosts BHP, Other Miners
- Exxon Mobil Expects Earnings and Cash Flow to Grow
- Sorrento Therapeutics, Scilex: 2 Hot Pharma Stocks On the Move
- Is The Great Alibaba Recovery About To Begin?
Receive News & Ratings for Alliance Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alliance Pharma and related companies with MarketBeat.com's FREE daily email newsletter.